Drug Shortage Report for CAVERJECT STERILE POWDER
| Report ID | 98076 |
| Drug Identification Number | 02215756 |
| Brand name | CAVERJECT STERILE POWDER |
| Common or Proper name | Caverject |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALPROSTADIL |
| Strength(s) | 23.2MCG |
| Dosage form(s) | KIT LIQUID POWDER FOR SOLUTION |
| Route of administration | INTRACAVERNOSAL |
| Packaging size | 5 x 20MCG VIALS |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-29 |
| Estimated end date | 2020-10-30 |
| Actual end date | 2020-10-26 |
| Shortage status | Resolved |
| Updated date | 2020-10-27 |
| Company comments | This shortage also includes : DIN 02215187 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2020-10-27 | English | Compare |
| v11 | 2020-10-26 | French | Compare |
| v10 | 2020-10-26 | English | Compare |
| v9 | 2020-10-15 | French | Compare |
| v8 | 2020-10-15 | English | Compare |
| v7 | 2020-08-03 | French | Compare |
| v6 | 2020-08-03 | English | Compare |
| v5 | 2020-02-10 | French | Compare |
| v4 | 2020-02-10 | English | Compare |
| v3 | 2020-02-10 | English | Compare |
| v2 | 2019-11-06 | French | Compare |
| v1 | 2019-11-06 | English | Compare |
Showing 1 to 12 of 12